Literature DB >> 22517588

Musashi 2 in hematopoiesis.

Luisa de Andrés-Aguayo1, Florencio Varas, Thomas Graf.   

Abstract

PURPOSE OF REVIEW: Recent work has shown that the Musashi 2 (Msi2) gene plays important roles in normal and malignant hematopoiesis. Here, we give an overview on the role of Msi2 in the regulation and function of primitive hematopoietic cells as well as in leukaemic progression. We also discuss the molecular pathways in which Msi2 acts in both normal and leukaemic blood cells. RECENT
FINDINGS: Msi2 gain and loss of function experiments have shown that it plays an important role in regulating the heamatopoietic stem cell pool. Msi2 has also been found to be overexpressed in human myeloid leukaemias correlating with poor prognosis, therefore Msi2 may be considered as a prognostic marker for acute myeloid leukaemia.
SUMMARY: Further studies into the molecular pathways through which Msi2 modulates primitive progenitor function will provide insight into the regulation of normal haematopoiesis and a better understanding of the mechanisms governing the leukaemic transformation process. This will be crucial for the development of effective therapies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22517588     DOI: 10.1097/MOH.0b013e328353c778

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  21 in total

1.  The genomic response of human granulosa cells (KGN) to melatonin and specific agonists/antagonists to the melatonin receptors.

Authors:  Asma Arjoune; Marc-André Sirard
Journal:  Sci Rep       Date:  2022-10-20       Impact factor: 4.996

2.  The Novel KLF4/MSI2 Signaling Pathway Regulates Growth and Metastasis of Pancreatic Cancer.

Authors:  Kun Guo; Jiujie Cui; Ming Quan; Dacheng Xie; Zhiliang Jia; Daoyan Wei; Liang Wang; Yong Gao; Qingyong Ma; Keping Xie
Journal:  Clin Cancer Res       Date:  2016-07-22       Impact factor: 12.531

3.  Tissue-specific control of brain-enriched miR-7 biogenesis.

Authors:  Nila Roy Choudhury; Flavia de Lima Alves; Luisa de Andrés-Aguayo; Thomas Graf; Javier F Cáceres; Juri Rappsilber; Gracjan Michlewski
Journal:  Genes Dev       Date:  2013-01-01       Impact factor: 11.361

4.  Musashi interaction with poly(A)-binding protein is required for activation of target mRNA translation.

Authors:  Chad E Cragle; Melanie C MacNicol; Stephanie D Byrum; Linda L Hardy; Samuel G Mackintosh; William A Richardson; Nicola K Gray; Gwen V Childs; Alan J Tackett; Angus M MacNicol
Journal:  J Biol Chem       Date:  2019-05-31       Impact factor: 5.157

Review 5.  RNA binding proteins in spermatogenesis: an in depth focus on the Musashi family.

Authors:  Jessie M Sutherland; Nicole A Siddall; Gary R Hime; Eileen A McLaughlin
Journal:  Asian J Androl       Date:  2015 Jul-Aug       Impact factor: 3.285

Review 6.  Functional Integration of mRNA Translational Control Programs.

Authors:  Melanie C MacNicol; Chad E Cragle; Karthik Arumugam; Bruno Fosso; Graziano Pesole; Angus M MacNicol
Journal:  Biomolecules       Date:  2015-07-21

7.  Neural stem and progenitor cell fate transition requires regulation of Musashi1 function.

Authors:  Angus M MacNicol; Linda L Hardy; Horace J Spencer; Melanie C MacNicol
Journal:  BMC Dev Biol       Date:  2015-03-18       Impact factor: 1.978

8.  Development of gene expression-based risk score in cytogenetically normal acute myeloid leukemia patients.

Authors:  Elias Bou Samra; Bernard Klein; Thérèse Commes; Jérôme Moreaux
Journal:  Oncotarget       Date:  2012-08

Review 9.  Specificity factors in cytoplasmic polyadenylation.

Authors:  Amanda Charlesworth; Hedda A Meijer; Cornelia H de Moor
Journal:  Wiley Interdiscip Rev RNA       Date:  2013 Jul-Aug       Impact factor: 9.957

10.  Musashi2 predicts poor prognosis and invasion in hepatocellular carcinoma by driving epithelial-mesenchymal transition.

Authors:  Lu He; Xinke Zhou; Chen Qu; Lijuan Hu; Yunqiang Tang; Qiong Zhang; Min Liang; Jian Hong
Journal:  J Cell Mol Med       Date:  2013-10-31       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.